Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Clementia Pharmaceuticals
company
About
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $60M
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. The company develops disease-modifying treatments for patients suffering from debilitating bone and other diseases with a high unmet medical need. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues.Clementia Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$60M
Clementia Pharmaceuticals has raised a total of
$60M
in funding over 2 rounds. Their latest funding was raised on
Jun 23, 2015 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 23, 2015 | Series Unknown | $60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Clementia Pharmaceuticals is funded by 1 investors.
UCB
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
UCB
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
